Clene (CLNN)
(Delayed Data from NSDQ)
$3.67 USD
+0.01 (0.27%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $3.68 +0.01 (0.27%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Clene Inc. has a market cap of $30.26M, which represents its share price of $3.66 multiplied by its outstanding shares number of 8.27M. As a small-cap company, CLNN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CLNN 3.67 +0.01(0.27%)
Will CLNN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLNN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLNN
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates
CLNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates
Clene Inc. (CLNN) Reports Q4 Loss, Lags Revenue Estimates
Clene Inc. (CLNN) Reports Q3 Loss, Misses Revenue Estimates
Other News for CLNN
Clene to Present at the Canaccord 45th Annual Growth Conference | CLNN Stock News
Clene (CLNN) Receives Consistent Buy Rating from D. Boral Capital | CLNN Stock News
12 Health Care Stocks Moving In Friday's After-Market Session
Clene (CLNN) Maintains "Buy" Rating with $23 Price Target | CLNN Stock News
Clene provides regulatory update following FDA Type C meeting